NAFDAC destroys N22.73bn worth of unwholesome products in eight months
By Kazeem Ugbodaga
The National Agency for Food and Drug Administration and Control (NAFDAC) has disclosed that it destroyed unwholesome products valued at approximately N22.73 billion between January and August 2026, as part of intensified efforts to rid the Nigerian market of dangerous and substandard goods.
The destruction, carried out through 22 separate exercises, formed part of the agency’s enforcement operations aimed at preventing unsafe, counterfeit and unwholesome products from reaching consumers and threatening public health.
NAFDAC Director-General, Prof. Mojisola Adeyeye, disclosed the figures while presenting the agency’s regulatory achievements at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting held in Prague, Czech Republic, from November 18 to 19, 2026.
The disclosure highlighted the scale of the agency’s enforcement activities and its efforts to strengthen regulatory oversight of products circulating in the country.
According to the presentation, NAFDAC conducted 5,542 enforcement activities within the eight-month period, alongside 213 raids, 821 product seizures and the closure of 179 premises linked to regulatory violations.
The operations also resulted in 52 arrests and 221 sanctions against individuals and businesses found to have violated applicable regulations.
The destruction of products worth N22.73 billion represents a significant component of the agency’s campaign to protect consumers from potentially harmful products, particularly those that fail to meet established safety and quality standards.
Beyond enforcement, Adeyeye highlighted progress in strengthening Nigeria’s pharmaceutical regulatory framework, noting that NAFDAC had sustained its World Health Organisation (WHO) Maturity Level 3 status while working towards achieving Maturity Level 4.
She attributed the agency’s regulatory advancement partly to digital transformation initiatives, including the Integrated Regulatory Information Management System (IRIMS), i-PMS, GMPi, artificial intelligence-assisted Technical Screening Tools and the revised Med Safety App.
The agency also reported progress in promoting domestic pharmaceutical manufacturing through its 5+5 Policy.
Under the policy, more than 70 per cent of finished pharmaceutical products covered by the initiative and Ceiling 36 are now locally manufactured, according to the presentation.
Adeyeye also highlighted NAFDAC‘s growing international and regional regulatory engagements, including technical capacity-building and institutional benchmarking programmes hosted for regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire.
The agency said the achievements demonstrate its commitment to strengthening regulatory systems, expanding digital innovation, supporting local pharmaceutical production and deepening international cooperation.
